PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects Against Breast Cancer Cells

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2022 Feb 26

PMID 35214139

Authors

Sherif Ashraf Fahmy

Asmaa Ramzy

Asmaa A Mandour

Soad Nasr

Anwar Abdelnaser

Udo Bakowsky

Hassan Mohamed El-Said Azzazy

Affiliations

Soon will be listed here.

Abstract

This study aims to design a pH-responsive dual-loaded nanosystem based on PEGylated chitosan nanoparticles loaded with ascorbic acid (AA) and oxaliplatin (OX) for the effective treatment of breast cancer. In this regard, non-PEGylated and PEGylated chitosan nanoparticles (CS NPs) loaded with either ascorbic acid (AA), oxaliplatin (OX), or dual-loaded with AA-OX were fabricated using the ionotropic gelation method. The hydrodynamic diameters of the fabricated AA/CS NPs, OX/CS NPs, and AA-OX/CS NPs were 157.20 ± 2.40, 188.10 ± 9.70, and 261.10 ± 9.19 nm, respectively. While the hydrodynamic diameters of the designed AA/PEG-CS NPs, OX/PEG-CS NPs, and AA-OX/PEG-CS NPs were 152.20 ± 2.40, 156.60 ± 4.82, and 176.00 ± 4.21 nm, respectively. The ζ-potential of the prepared nanoparticles demonstrated high positive surface charges of +22.02 ± 1.50, +22.58 ± 1.85 and +40.4 ± 2.71 mV for AA/CS NPs, OX/CS NPs, and AA-OX/CS NPs, respectively. The ζ-potential of the PEGylated CS NPs was reduced owing to the shielding of the positive charges by the PEG chains. Additionally, all the prepared nanoparticles exhibited high entrapment efficiencies (EE%) and spherical-shaped morphology. The chemical features of the prepared nanoparticles were investigated using Fourier transform infrared (FTIR) spectroscopy. Release studies showed the capability of the prepared non-PEGylated and PEGylated chitosan NPs to release their cargo in the acidic environment of cancer tissue (pH 5.5). Furthermore, the AA/CS NPs, AA/PEG-CS NPs, OX/CS NPs, OX/PEG-CS NPs, AA-OX/CS NPs and AA-OX/PEG-CS NPs exhibited remarkable cytotoxic activities against breast adenocarcinoma (MCF-7) cells with IC values of 44.87 ± 11.49, 23.3 ± 3.73, 23.88 ± 6.29, 17.98 ± 3.99, 18.69 ± 2.22, and 7.5 ± 0.69 µg/mL, respectively; as compared to free AA and OX (IC of 150.80 ± 26.50 and 147.70 ± 63.91 µg/mL, respectively). Additionally, treatment of MCF-7 cells with IC concentrations of AA, AA/CS NPs, AA/PEG-CS NPs, OX, OX/CS NPs, OX/PEG-CS NPs, AA-OX/CS NPs or AA-OX/PEG-CS NPs increased the percentages of early apoptotic cells to 5.28%, 9.53%, 11.20%, 5.27%, 13.80%, 8.43%, 2.32%, and 10.10%, respectively, and increased the percentages of late apoptotic cells to 0.98%, 0.37%, 2.41%, 2.06%, 0.97%, 9.66%, 56%, and 81.50%, respectively. These results clearly indicate that PEGylation enhances the apoptotic effect of AA and OX alone, in addition to potentiating the apoptotic effect of AA and OX when combined on MCF-7 cells. In conclusion, PEGylated chitosan nanoparticles encapsulating AA, OX, or AA and OX represent an effective formula for induction of apoptosis in MCF-7 cells.

Citing Articles

A rapid protocol for synthesis of chitosan nanoparticles with ideal physicochemical features.

Dadashi H, Vandghanooni S, Karamnejad-Faragheh S, Karimian-Shaddel A, Eskandani M, Jahanban-Esfahlan R Heliyon. 2024; 10(11):e32228.

PMID: 38961950 PMC: 11219308. DOI: 10.1016/j.heliyon.2024.e32228.

Recent Innovations of Mesoporous Silica Nanoparticles Combined with Photodynamic Therapy for Improving Cancer Treatment.

Nady D, Hassan A, Amin M, Bakowsky U, Fahmy S Pharmaceutics. 2024; 16(1).

PMID: 38276492 PMC: 10821275. DOI: 10.3390/pharmaceutics16010014.

Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.

Bagheri M, Zandieh M, Daryab M, Samaei S, Gholami S, Rahmanian P Transl Oncol. 2023; 39:101838.

PMID: 38016356 PMC: 10698329. DOI: 10.1016/j.tranon.2023.101838.

PEGylated Chitosan Nanoparticles Loaded with Betaine and Nedaplatin Hamper Breast Cancer: In Vitro and In Vivo Studies.

Fahmy S, Ramzy A, El Samaloty N, Sedky N, Azzazy H ACS Omega. 2023; 8(44):41485-41494.

PMID: 37969975 PMC: 10633871. DOI: 10.1021/acsomega.3c05359.

Nedaplatin/ Alkaloids Co-Loaded Electrospun, Implantable Nanofibers: A Chemopreventive Nano-Delivery System for Treating and Preventing Breast Cancer Recurrence after Tumorectomy.

Sedky N, Arafa K, Abdelhady M, Issa M, Abdel-Kader N, Mahdy N Pharmaceutics. 2023; 15(10).

PMID: 37896127 PMC: 10609766. DOI: 10.3390/pharmaceutics15102367.

References

Igney F, Krammer P . Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002; 2(4):277-88. DOI: 10.1038/nrc776. View

Singla A, Chawla M . Chitosan: some pharmaceutical and biological aspects--an update. J Pharm Pharmacol. 2001; 53(8):1047-67. DOI: 10.1211/0022357011776441. View

Espey M, Chen P, Chalmers B, Drisko J, Sun A, Levine M . Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med. 2011; 50(11):1610-9. PMC: 3482496. DOI: 10.1016/j.freeradbiomed.2011.03.007. View

Rao K, Roome T, Aziz S, Razzak A, Abbas G, Imran M . Bergenin loaded gum xanthan stabilized silver nanoparticles suppress synovial inflammation through modulation of the immune response and oxidative stress in adjuvant induced arthritic rats. J Mater Chem B. 2020; 6(27):4486-4501. DOI: 10.1039/c8tb00672e. View

Tummala S, Gowthamarajan K, Satish Kumar M, Wadhwani A . Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors. Drug Deliv. 2015; 23(5):1773-87. DOI: 10.3109/10717544.2015.1084400. View

Wu C, Liu H, Yu Y, Hung Y, Wei C, Yiang G . Combined treatment with vitamin C and methotrexate inhibits triple-negative breast cancer cell growth by increasing H2O2 accumulation and activating caspase-3 and p38 pathways. Oncol Rep. 2017; 37(4):2177-2184. DOI: 10.3892/or.2017.5439. View

Boonsongrit Y, Mueller B, Mitrevej A . Characterization of drug-chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry. Eur J Pharm Biopharm. 2008; 69(1):388-95. DOI: 10.1016/j.ejpb.2007.11.008. View

Gilloteaux J, Jamison J, Neal D, Summers J . Synergistic antitumor cytotoxic actions of ascorbate and menadione on human prostate (DU145) cancer cells in vitro: nucleus and other injuries preceding cell death by autoschizis. Ultrastruct Pathol. 2014; 38(2):116-40. DOI: 10.3109/01913123.2013.852645. View

Fahmy S, Ponte F, Fawzy I, Sicilia E, Bakowsky U, Azzazy H . Host-Guest Complexation of Oxaliplatin and Sulfonatocalix[n]Arenes for Potential Use in Cancer Therapy. Molecules. 2020; 25(24). PMC: 7765097. DOI: 10.3390/molecules25245926. View

10.

Zhang X, Teng D, Wu Z, Wang X, Wang Z, Yu D . PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release. J Mater Sci Mater Med. 2008; 19(12):3525-33. DOI: 10.1007/s10856-008-3500-8. View

11.

Calvo P, Remunan-Lopez C, Alonso M . Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997; 14(10):1431-6. DOI: 10.1023/a:1012128907225. View

12.

Wu L, Man C, Wang H, Lu X, Ma Q, Cai Y . PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin. Pharm Res. 2012; 30(2):412-23. DOI: 10.1007/s11095-012-0883-5. View

13.

Abdel-Hafez S, Hathout R, Sammour O . Tracking the transdermal penetration pathways of optimized curcumin-loaded chitosan nanoparticles via confocal laser scanning microscopy. Int J Biol Macromol. 2017; 108:753-764. DOI: 10.1016/j.ijbiomac.2017.10.170. View

14.

Adhikari H, Nath Yadav P . Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action. Int J Biomater. 2019; 2018:2952085. PMC: 6332982. DOI: 10.1155/2018/2952085. View

15.

Baghdan E, Pinnapireddy S, Strehlow B, Engelhardt K, Schafer J, Bakowsky U . Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery. Int J Pharm. 2017; 535(1-2):473-479. DOI: 10.1016/j.ijpharm.2017.11.045. View

16.

Pires A, Marques C, Encarnacao J, Abrantes A, Marques I, Laranjo M . Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth. Front Physiol. 2018; 9:911. PMC: 6064950. DOI: 10.3389/fphys.2018.00911. View

17.

Imran M, Raza Shah M, Ullah F, Ullah S, Sadiq A, Ali I . Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime. Artif Cells Nanomed Biotechnol. 2016; 45(7):1440-1451. DOI: 10.1080/21691401.2016.1246451. View

18.

Fahmy S, Ponte F, Abd El-Rahman M, Russo N, Sicilia E, Shoeib T . Investigation of the host-guest complexation between 4-sulfocalix[4]arene and nedaplatin for potential use in drug delivery. Spectrochim Acta A Mol Biomol Spectrosc. 2018; 193:528-536. DOI: 10.1016/j.saa.2017.12.070. View

19.

Silva M, Calado R, Marto J, Bettencourt A, Almeida A, Goncalves L . Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration. Mar Drugs. 2017; 15(12). PMC: 5742830. DOI: 10.3390/md15120370. View

20.

Fahmy S, Fawzy I, Saleh B, Issa M, Bakowsky U, Azzazy H . Green Synthesis of Platinum and Palladium Nanoparticles Using L. Seed Alkaloids: Biological and Computational Studies. Nanomaterials (Basel). 2021; 11(4). PMC: 8103518. DOI: 10.3390/nano11040965. View